CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating expenses:
Research and development	$ 6,083,167	$ 5,414,760
General and administrative	2,760,208	3,316,156
Total operating expenses	8,843,375	8,730,916
Operating loss	(8,843,375)	(8,730,916)
Gain on derivative instruments	364,596	932,836
Other non-operating gains	(30,793)	121,606
Interest expense, net	(273,034)	(260,390)
Net loss	(8,782,606)	(7,936,864)
Modification of warrants		(85,779)
Net loss available to common shareholders	$ (8,782,606)	$ (8,022,643)
Net loss per common share
BASIC and DILUTED	$ (0.20)	$ (0.21)
Weighted average common shares outstanding
BASIC	43,077,961	38,670,247
DILUTED	43,083,420	38,767,286